KPNA2 and non-small cell lung carcinoma: Furthermore, recent work identified KPNA2 as a potential prognostic marker for the progression of prostate cancer [36], non-muscle-invasive bladder cancer [37], as well as non-small cell lung cancer [38], hepatocellular carcinoma.